From: Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib
Variable (N = 137)
PFS
HR
95%CI
Multivariate (P value)
TC
1.841
1.187–2.857
0.006
  < 4.77
  ≥ 4.77
LDL
2.133
1.336–3.406
0.002
  < 2.965
  ≥ 2.965